IPHA

Innate Pharma
IPHA

7 hedge funds and large institutions have $760K invested in Innate Pharma in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

87% less capital invested

Capital invested by funds: $5.71M → $760K (-$4.95M)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$220K
2
+$109K
3
+$52K
4
Osaic Holdings
Osaic Holdings
Arizona
+$9K

Top Sellers

1
-$5.46M
2
-$21.4K
3
-$1.94K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$242K
2
$214K
3
$131K
4
$109K
5
$52K
6
$9K
7
$2.8K
8
–